Skip to main content
Gland Pharma Limited logo

Gland Pharma Limited — Investor Relations & Filings

Ticker · GLAND ISIN · INE068V01023 LEI · 335800JJVDY5R6KF5K34 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2023-02-24 Investor Presentation
Country IN India
Listing BSE.NS GLAND

About Gland Pharma Limited

https://glandpharma.com

Gland Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) focused on injectable formulations. The company operates primarily through a business-to-business (B2B) model, providing development and manufacturing services for a diverse range of sterile injectables. Its portfolio encompasses complex generics across various therapeutic areas, including oncology, ophthalmology, anti-infectives, and orthopedics. Gland Pharma maintains a vertically integrated supply chain, ensuring control over critical raw materials and active pharmaceutical ingredients. The company serves a global market, with a significant presence in regulated regions such as the United States, Europe, Canada, and Australia. Its manufacturing facilities adhere to international quality standards and hold approvals from major regulatory bodies. Key strengths include expertise in niche segments like heparin and enoxaparin, alongside a robust pipeline of complex delivery systems.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter addressed to stock exchanges notifying them of the schedule for an analyst/institutional investor meeting. It references compliance with SEBI regulations and provides details of a virtual one-on-one call with an investment management firm. The content is an announcement of a meeting rather than a financial report, earnings release, or detailed presentation. The document length is short (1524 characters), and it does not contain financial data or analysis. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor communication, specifically scheduling of investor meetings.
2023-02-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 23, 2023, addressed to stock exchanges regarding the schedule of an Analyst/Institutional Investor Meeting. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which governs disclosure of material events. The content is purely an announcement of a meeting schedule with no financial data, analysis, or detailed presentation included. The document length is only 1530 characters, indicating it is a brief notice rather than a full report or transcript. Therefore, it fits the category of an Investor Presentation announcement or meeting schedule notice. However, since it is only a schedule intimation and not the presentation itself, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-02-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 10, 2023, addressed to stock exchanges, informing them about the schedule of an Analyst/Institutional Investor Meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which mandates disclosure of such meetings. The content is a simple intimation of a meeting schedule, not a detailed investor presentation or financial report. The document length is only 1519 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Investor Presentation announcements or meeting schedule notifications. However, since it is only an intimation of the schedule and not the presentation itself, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 95% confidence The document is a short notice dated February 7, 2023, addressed to stock exchanges regarding the schedule of an Analyst/Institutional Investor Meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure of material events. The content is an intimation about the schedule of investor meetings, not a detailed financial report or presentation. The document length is only 1555 characters, indicating it is a brief announcement rather than a full report or transcript. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investor relations and meetings, which are typically categorized under capital market communications and updates.
2023-02-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 6, 2023, addressed to stock exchanges regarding the schedule of an Analyst/Institutional Investor Meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure of material events. The content is an announcement of a meeting schedule, not a report or transcript of the meeting itself. The document length is only 1505 characters, indicating it is a brief announcement rather than a detailed report or transcript. Therefore, it fits the category of Investor Presentation (IP) related announcements or meetings. However, since it only announces the schedule of the meeting and does not contain the presentation or transcript, it is best classified as a Regulatory Filing (RNS) as a general disclosure notice. Given the specificity of the categories, and that it is a regulatory announcement about an investor meeting schedule, the most appropriate classification is Regulatory Filings (RNS).
2023-02-06 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding a newspaper advertisement about the dispatch of a Notice of Postal Ballot and e-voting information. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content focuses on the announcement of the dispatch of voting materials to shareholders and related procedural information. There is no detailed financial data, management discussion, or report content. The document is essentially an announcement related to shareholder voting procedures, not the voting results themselves or the full notice. Given the nature of the document as an announcement about the dispatch of a notice for postal ballot and e-voting, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document rather than a full report or voting results declaration.
2023-02-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.